CervoMed Inc. — Director's Dealing 2016

Jan 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RestorGenex Corp (RESX)
CIK: 0001053691
Period of Report: 2016-01-08

Reporting Person: LEVIN ALAN G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-08	Common Stock	A	248032	—	Acquired	248032	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-08	Stock Option (Right to Buy)	$0.42	A	276140	Acquired	2025-06-15	Common Stock (276140)	Direct
2016-01-08	Stock Option (Right to Buy)	$0.55	A	365265	Acquired	2025-10-30	Common Stock (365265)	Direct

Footnotes

F1: 184,093 of the shares are shares of restricted common stock which vest in equal parts each month until fully vested on the third anniversary of the original grant date, June 15, 2015.

F2: Received in exchange for 67,905 units of Diffusion Pharmaceuticals LLC ("Diffusion") in connection with the consummation of the merger (the "Merger") of Diffusion and a wholly-owned subsidiary of the Issuer ("Merger Sub") on January 8, 2016 based upon the exchange rate set forth in the Agreement and Plan of Merger, dated December 15, 2015, by and among the Issuer, Diffusion and Merger Sub.

F3: In connection with the consummation of the Merger, an option originally granted on June 15, 2015 to purchase membership units in Diffusion was converted into an option to purchase common stock of the Issuer.

F4: The shares underlying the options vest in equal parts each month until fully vested on the third anniversary of the grant date.

F5: In connection with the consummation of the Merger, an option originally granted on October 30, 2015 to purchase membership units in Diffusion was converted into an option to purchase common stock of the Issuer.